AU7019200A - Nucleoside analogues - Google Patents

Nucleoside analogues

Info

Publication number
AU7019200A
AU7019200A AU70192/00A AU7019200A AU7019200A AU 7019200 A AU7019200 A AU 7019200A AU 70192/00 A AU70192/00 A AU 70192/00A AU 7019200 A AU7019200 A AU 7019200A AU 7019200 A AU7019200 A AU 7019200A
Authority
AU
Australia
Prior art keywords
nucleoside analogues
nucleoside
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70192/00A
Inventor
William Jonathan Cummins
Robert James Domett Nairne
Clifford Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
Nycomed Amersham PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Amersham PLC filed Critical Nycomed Amersham PLC
Publication of AU7019200A publication Critical patent/AU7019200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU70192/00A 1999-08-31 2000-08-30 Nucleoside analogues Abandoned AU7019200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99306887 1999-08-31
EP99306887 1999-08-31
PCT/GB2000/003301 WO2001016150A2 (en) 1999-08-31 2000-08-30 Nucleoside analogues

Publications (1)

Publication Number Publication Date
AU7019200A true AU7019200A (en) 2001-03-26

Family

ID=8241600

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70192/00A Abandoned AU7019200A (en) 1999-08-31 2000-08-30 Nucleoside analogues

Country Status (5)

Country Link
EP (1) EP1208109A2 (en)
JP (1) JP2003508406A (en)
AU (1) AU7019200A (en)
CA (1) CA2382324A1 (en)
WO (1) WO2001016150A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565480B1 (en) 2002-11-22 2018-08-22 Roche Diagnostics GmbH Detectable labeled nucleoside analogs and methods of use thereof
US7977108B2 (en) 2005-07-25 2011-07-12 Roche Molecular Systems, Inc. Method for detecting a mutation in a repetitive nucleic acid sequence

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61171497A (en) * 1985-01-25 1986-08-02 Takeda Chem Ind Ltd Lure nucleotide
WO1994021658A1 (en) * 1993-03-15 1994-09-29 Kalman Thomas I Antiviral imidazolinone nucleoside derivatives
IL129126A0 (en) * 1996-10-16 2000-02-17 Icn Pharmaceuticals Monocyclic l-nucleosides analogs and uses thereof

Also Published As

Publication number Publication date
EP1208109A2 (en) 2002-05-29
WO2001016150A3 (en) 2001-11-15
JP2003508406A (en) 2003-03-04
CA2382324A1 (en) 2001-03-08
WO2001016150A2 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
AU5515901A (en) Gamma-phosphoester nucleoside triphosphates
AUPQ105499A0 (en) Antiviral agents
HUP0202812A3 (en) Novel bicyclonucleoside analogues
HUP0203485A3 (en) Purine derivatives
GB9913932D0 (en) Purine derivatives
IL146342A0 (en) Purine derivatives
AU8334298A (en) Nociceptin analogues
AUPQ288499A0 (en) Antiviral agents
PL364768A1 (en) Vitamin d analogues
PL355432A1 (en) Vitamin d analogues
AU5691800A (en) Structure
AU1016701A (en) Helicopter-car aircraft
AU2201501A (en) Structure
AU2002218151A1 (en) Pna analogues
AU1042701A (en) Antiviral combinations
EP1211241A4 (en) Prostaglandin e analogues
AU6550800A (en) Hepoxilin analogs
AU7019200A (en) Nucleoside analogues
AU3086800A (en) Injection-administered antiviral preparation
AU5460700A (en) Protected nucleosides
AU1905601A (en) Aircraft
AU5056900A (en) Weight-shift-controlled airplane
AU3809500A (en) Expression
AU6016200A (en) Coumarone analogues
AU5686900A (en) Antiviral tetrahydroisichinolinsulfonamides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase